Everything you care about in one place

Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.

Get Feeder

ema.europa.eu

What's new

Get the latest updates from What's new directly as they happen.

Follow now 449 followers

Latest posts

Last updated about 1 hour ago

Expert panel support for breakthrough medical devices: pilot programme

7 days ago

Expert panel support for breakthrough medical devices: pilot programme

Human medicines European public assessment report (EPAR): Cibinqo, abrocitinib, Date of authorisation: 09/12/2021, Revision: 18, Status: Authorised

6 days ago

Human medicines European public assessment report (EPAR): Cibinqo, abrocitinib, Date of authorisation...

Human medicines European public assessment report (EPAR): Ezmekly, mirdametinib, Date of authorisation: 17/07/2025, Revision: 4, Status: Authorised

6 days ago

Human medicines European public assessment report (EPAR): Ezmekly, mirdametinib, Date of authorisation...

Human medicines European public assessment report (EPAR): Lupkynis, voclosporin, Date of authorisation: 15/09/2022, Revision: 8, Status: Authorised

about 4 hours ago

Human medicines European public assessment report (EPAR): Lupkynis, voclosporin, Date of authorisation...

Human medicines European public assessment report (EPAR): Benlysta, belimumab, Date of authorisation: 13/07/2011, Revision: 41, Status: Authorised

about 2 hours ago

Human medicines European public assessment report (EPAR): Benlysta, belimumab, Date of authorisation...

Human medicines European public assessment report (EPAR): Sivextro, tedizolid phosphate, Date of authorisation: 23/03/2015, Revision: 26, Status: Authorised

about 2 hours ago

Human medicines European public assessment report (EPAR): Sivextro, tedizolid phosphate, Date of...

Human medicines European public assessment report (EPAR): Suliqua, insulin glargine,lixisenatide, Date of authorisation: 11/01/2017, Revision: 16, Status: Authorised

about 2 hours ago

Human medicines European public assessment report (EPAR): Suliqua, insulin glargine,lixisenatide, Date of...

Human medicines European public assessment report (EPAR): Lucentis, ranibizumab, Date of authorisation: 22/01/2007, Revision: 49, Status: Authorised

about 3 hours ago

Human medicines European public assessment report (EPAR): Lucentis, ranibizumab, Date of authorisation...

Human medicines European public assessment report (EPAR): Kavigale, sipavibart, Date of authorisation: 20/01/2025, Revision: 5, Status: Authorised

about 4 hours ago

Human medicines European public assessment report (EPAR): Kavigale, sipavibart, Date of authorisation...